
|Articles|July 11, 2012
Cost Implications of Pertuzumab/Trastuzumab Combination
In this segment, panelists address coverage strategies health plans may utilize to finance patient access to the combination treatment.
Advertisement
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
Andes Hantavirus FAQs: What to Know as Quarantined Cruise Passengers Return Home
2
Rituximab Suppresses Clinical Relapses, MRI Activity in Pediatric MS
3
FDA Issues Complete Response Letter for Cingulate's Once-Daily ADHD Drug CTx-1301
4
New Therapies Offer Hope for Vitiligo, an Often Misunderstood and Undertreated Disease
5




